{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:53:37Z","timestamp":1790610817080,"version":"4.1.0"},"reference-count":30,"publisher":"BMJ","issue":"12","license":[{"start":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T00:00:00Z","timestamp":1638403200000},"content-version":"unspecified","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"crossref","award":["GR-2018-12365475"],"award-info":[{"award-number":["GR-2018-12365475"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2021,11,12]]},"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Epilepsy is a chronic condition requiring consistent follow-up aimed at seizure control, and monitoring of anti-seizure medication (ASM) levels and side effects. Telemedicine (TM) offers invaluable support to patient follow-up, guaranteeing the prompt availability of a team of experts for persons with epilepsy (PWE) widely distributed across the country. Although many health institutions have endorsed the use of TM, robust data on effectiveness, safety and costs of TM applied to epilepsy are lacking. TELEmedicine for EPIlepsy Care (TELE-EPIC) will evaluate the effectiveness of video consultation (VC) via TM compared with usual care (UC) for the monitoring of PWE (TELE-EPIC_RCT). Moreover, TELE-EPIC will apply an innovative Volumetric Absorptive Microsampling (VAMS) device for quantitation of ASM through finger prick blood sampling as an alternative to venipuncture sampling (TELE-EPIC_VAMS).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and analysis<\/jats:title>\n                  <jats:p>TELE-EPIC_RCT is a multicentre, open, pragmatic two-arm randomised controlled trial prospectively including adult and paediatric outpatients with established diagnosis of epilepsy consecutively attending the Epilepsy Centres of Bologna and Rome, respectively. The primary outcome is the non-inferiority of VC on seizure control compared with UC after an 18-month follow-up. Secondary outcomes are adherence to treatment, ASM-related adverse events, quality of life, mood disorders, patient and caregiver satisfaction, safety and costs. TELE-EPIC_VAMS is a cross-validation study for blood ASM quantitation through a novel, VAMS-based device, comparing (1) VAMS versus plasma samples (reference standard method); and (2) nurse-collected versus self-collected blood by VAMS device.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Ethics and dissemination<\/jats:title>\n                  <jats:p>The study has been approved by the local ethics committee (349-2019-SPER-AUSLBO). Complete information about the state of project, relevant events and results will be regularly updated on the project\u2019s webpage on ClinicalTrials.gov. The project\u2019s results and data on the potential impact of TM in epilepsy will be disseminated on social media. A closeout meeting will be convened for the communication and dissemination of the project, highlighting its main achievements and impacts.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial registration number<\/jats:title>\n                  <jats:p>\n                     <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT04496310\">NCT04496310<\/jats:ext-link>\n                  <\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjopen-2021-053980","type":"journal-article","created":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T12:01:29Z","timestamp":1638532889000},"page":"e053980","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":15,"title":["TELEmedicine for EPIlepsy Care (TELE-EPIC): protocol of a randomised, open controlled non-inferiority clinical trial"],"prefix":"10.1136","volume":"11","clinical-trial-number":[{"clinical-trial-number":"nct04496310","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7979-9895","authenticated-orcid":false,"given":"Laura","family":"Licchetta","sequence":"first","affiliation":[{"name":"IRCCS, Instituto delle Scienze Neurologiche di Bologna, Full Member of European Reference Network EpiCARE, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Trivisano","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Rare and Complex Epilepsies Unit, Bambino Ges\u00f9 Children\"s Hospital, IRCCS, Full Member of European Reference Network EpiCARE, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Baldin","sequence":"additional","affiliation":[{"name":"Epidemiology and Statistics Unit, IRCCS, Instituto delle Scienze Neurologiche di Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Mohamed","sequence":"additional","affiliation":[{"name":"IRCCS, Instituto delle Scienze Neurologiche di Bologna, Full Member of European Reference Network EpiCARE, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0487-7996","authenticated-orcid":false,"given":"Emanuel","family":"Raschi","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, Pharmacology Unit, University of Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Mostacci","sequence":"additional","affiliation":[{"name":"IRCCS, Instituto delle Scienze Neurologiche di Bologna, Full Member of European Reference Network EpiCARE, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrado","family":"Zenesini","sequence":"additional","affiliation":[{"name":"Epidemiology and Statistics Unit, IRCCS, Instituto delle Scienze Neurologiche di Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Contin","sequence":"additional","affiliation":[{"name":"IRCCS, Instituto delle Scienze Neurologiche di Bologna, Full Member of European Reference Network EpiCARE, Bologna, Italy"},{"name":"Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Vigevano","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Rare and Complex Epilepsies Unit, Bambino Ges\u00f9 Children\"s Hospital, IRCCS, Full Member of European Reference Network EpiCARE, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Bisulli","sequence":"additional","affiliation":[{"name":"IRCCS, Instituto delle Scienze Neurologiche di Bologna, Full Member of European Reference Network EpiCARE, Bologna, Italy"},{"name":"Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Tinuper","sequence":"additional","affiliation":[{"name":"IRCCS, Instituto delle Scienze Neurologiche di Bologna, Full Member of European Reference Network EpiCARE, Bologna, Italy"},{"name":"Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9051-7091","authenticated-orcid":false,"given":"Luca","family":"Vignatelli","sequence":"additional","affiliation":[{"name":"Epidemiology and Statistics Unit, IRCCS, Instituto delle Scienze Neurologiche di Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,12,3]]},"reference":[{"key":"2025101814503786000_11.12.e053980.1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003509"},{"key":"2025101814503786000_11.12.e053980.2","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-014-0444-x"},{"key":"2025101814503786000_11.12.e053980.3","doi-asserted-by":"crossref","DOI":"10.1111\/j.1528-1167.2007.01222.x","article-title":"Psychiatric comorbidity in epilepsy: a population-based analysis","volume":"48","author":"Tellez-Zenteno","year":"2007","journal-title":"Epilepsia"},{"key":"2025101814503786000_11.12.e053980.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2009.06.003"},{"key":"2025101814503786000_11.12.e053980.5","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s00431-017-2958-0","article-title":"Seizure disorders and developmental disorders: impact on life of affected families\u2014a structured interview","volume":"176","author":"Spindler","year":"2017","journal-title":"Eur J Pediatr"},{"key":"2025101814503786000_11.12.e053980.6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1528-1157.43.s.4.2.x","article-title":"The economic cost of epilepsy: a review of the literature","volume":"43","author":"Begley","year":"2002","journal-title":"Epilepsia"},{"key":"2025101814503786000_11.12.e053980.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61689-4"},{"key":"2025101814503786000_11.12.e053980.8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60456-6"},{"key":"2025101814503786000_11.12.e053980.9","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(12)70153-9"},{"key":"2025101814503786000_11.12.e053980.10","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2004.045690"},{"key":"2025101814503786000_11.12.e053980.11","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/j.euroneuro.2015.07.027","article-title":"Adverse cognitive effects of antiepileptic pharmacotherapy: each additional drug matters","volume":"25","author":"Witt","year":"2015","journal-title":"Eur Neuropsychopharmacol"},{"key":"2025101814503786000_11.12.e053980.12","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jchromb.2017.11.005","article-title":"Carbamazepine, lamotrigine, levetiracetam and valproic acid in dried blood spots with liquid chromatography tandem mass spectrometry; method development and validation","volume":"1072","author":"Linder","year":"2018","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"2025101814503786000_11.12.e053980.13","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.aca.2018.09.004","article-title":"Tutorial: volumetric absorptive microsampling (VAMS)","volume":"1046","author":"Protti","year":"2019","journal-title":"Anal Chim Acta"},{"key":"2025101814503786000_11.12.e053980.14","unstructured":"WHO . Global observatory for ehealth, 2010. Available: http:\/\/www.who.int\/goe\/publications\/goe_telemedicine_2010.pdf"},{"key":"2025101814503786000_11.12.e053980.15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.dsx.2020.04.001","article-title":"Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: guidelines for physicians","volume":"14","author":"Ghosh","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"2025101814503786000_11.12.e053980.16","article-title":"Efficacy and cost effectiveness of telemedicine for improving access to care in the Paris region: study protocols for eight trials","volume":"16","author":"Charrier","year":"2016","journal-title":"BMC Health Serv Res"},{"key":"2025101814503786000_11.12.e053980.17","first-page":"CD002098","article-title":"Interactive telemedicine: effects on professional practice and health care outcomes","volume":"2016","author":"Flodgren","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2025101814503786000_11.12.e053980.18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.seizure.2017.11.003","article-title":"Telephonic review for outpatients with epilepsy-a prospective randomized, parallel group study","volume":"53","author":"Bahrani","year":"2017","journal-title":"Seizure"},{"key":"2025101814503786000_11.12.e053980.19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2005.44804.x"},{"key":"2025101814503786000_11.12.e053980.20","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1528-1167.2007.01464.x","article-title":"Feasibility of epilepsy follow-up care through telemedicine: a pilot study on the patient\u2019s perspective","volume":"49","author":"Ahmed","year":"2008","journal-title":"Epilepsia"},{"key":"2025101814503786000_11.12.e053980.21","doi-asserted-by":"crossref","first-page":"107483","DOI":"10.1016\/j.yebeh.2020.107483","article-title":"SARS-CoV-2-related rapid reorganization of an epilepsy outpatient clinic from personal appointments to telemedicine services: a German single-center experience","volume":"112","author":"Willems","year":"2020","journal-title":"Epilepsy Behav"},{"key":"2025101814503786000_11.12.e053980.22","doi-asserted-by":"crossref","first-page":"107493","DOI":"10.1016\/j.yebeh.2020.107493","article-title":"Telemedicine, drug-resistant epilepsy, and ketogenic dietary therapies: a patient survey of a pediatric remote-care program during the COVID-19 pandemic","volume":"112","author":"Semprino","year":"2020","journal-title":"Epilepsy Behav"},{"key":"2025101814503786000_11.12.e053980.23","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-017-0572-8"},{"key":"2025101814503786000_11.12.e053980.24","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/FTD.0000000000000652","article-title":"Volumetric absorptive microsampling: a new sampling tool for therapeutic drug monitoring of antiepileptic drugs","volume":"41","author":"D\u02bcUrso","year":"2019","journal-title":"Ther Drug Monit"},{"key":"2025101814503786000_11.12.e053980.25","doi-asserted-by":"crossref","DOI":"10.1186\/s12883-020-01762-9","article-title":"Protocols of a diagnostic study and a randomized controlled non-inferiority trial comparing televisits vs standard in-person outpatient visits for narcolepsy diagnosis and care: telemedicine for narcolepsy (TENAR)","volume":"20","author":"Ingravallo","year":"2020","journal-title":"BMC Neurol"},{"key":"2025101814503786000_11.12.e053980.26","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13709"},{"key":"2025101814503786000_11.12.e053980.27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2009.02397.x"},{"key":"2025101814503786000_11.12.e053980.28","unstructured":"EMEA\/CHMP\/EWP\/192217\/2009, Committee for Medicinal Products for Human Use (CHMP) . EMA guideline on bioanalytical method validation, 2011."},{"key":"2025101814503786000_11.12.e053980.29","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41746-021-00412-9","article-title":"Applications of digital health for public health responses to COVID-19: a systematic scoping review of artificial intelligence, telehealth and related technologies","volume":"4","author":"Gunasekeran","year":"2021","journal-title":"NPJ Digit Med"},{"key":"2025101814503786000_11.12.e053980.30","doi-asserted-by":"crossref","first-page":"107376","DOI":"10.1016\/j.yebeh.2020.107376","article-title":"An accelerated shift in the use of remote systems in epilepsy due to the COVID-19 pandemic","volume":"112","author":"Kuchenbuch","year":"2020","journal-title":"Epilepsy Behav"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2021-053980","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:50:45Z","timestamp":1760824245000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2021-053980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":30,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,12,3]]},"published-print":{"date-parts":[[2021,12]]}},"alternative-id":["10.1136\/bmjopen-2021-053980"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2021-053980","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]}}}